Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT00343369
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosed with acute B-precursor or T-cell acute lymphoblastic leukemia (ALL)
* Meets 1 of the following risk criteria:
* Low-risk disease, defined by any of the following:
* WBC \< 25/nL
* B-precursor ALL
* Excluding pro-B ALL
* High-risk disease, defined by any of the following:
* WBC ≥ 25/nL
* T-cell ALL or pro-B ALL
* Chromosomal translocation 4/11
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* More than 7 days since prior therapy with steroids, vincristine, or daunorubicin hydrochloride
* More than 7 days since prior cytotoxic therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
18 Years
Study:
NCT00343369
Study Brief:
Protocol Section:
NCT00343369